Literature DB >> 1845910

Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T-, non-B-cell lymphomas.

D Bergeron1, L Poliquin, C A Kozak, E Rassart.   

Abstract

The Cas-Br-E murine leukemia virus is a nondefective retrovirus that induces non-T-, non-B-cell lymphomas in susceptible NIH/Swiss mice. By using a DNA probe derived from Cas-Br-E provirus-flanking sequences, we identified a DNA region, originally called Sic-1, rearranged in 16 of 24 tumors analyzed (67%). All proviruses were integrated in a DNA segment smaller than 100 bp and were in the same 5'-to-3' orientation. Ecotropic as well as mink cell focus-forming virus types were found integrated in that specific DNA region. On the basis of Southern blot analysis of somatic cell hybrids and progeny of an interspecies backcross, the Sic-1 region was localized on mouse chromosome 9 near the previously described proto-oncogenes or common viral integration sites: Ets-1, Cbl-2, Tpl-1, and Fli-1. Restriction map analysis shows that this region is identical to the Fli-1 locus identified in Friend murine leukemia virus-induced erythroleukemia cell lines and thus may contain sequences also responsible for the development of mouse non-T-, non-B-cell lymphomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845910      PMCID: PMC240483     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors.

Authors:  M L Mucenski; B A Taylor; J N Ihle; J W Hartley; H C Morse; N A Jenkins; N G Copeland
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

2.  Spi-1 is a putative oncogene in virally induced murine erythroleukaemias.

Authors:  F Moreau-Gachelin; A Tavitian; P Tambourin
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

3.  Moloney murine leukemia virus-induced myeloid tumors in adult BALB/c mice: requirement of c-myb activation but lack of v-abl involvement.

Authors:  G L Shen-Ong; L Wolff
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases.

Authors:  G Selten; H T Cuypers; W Boelens; E Robanus-Maandag; J Verbeek; J Domen; C van Beveren; A Berns
Journal:  Cell       Date:  1986-08-15       Impact factor: 41.582

5.  Highly preferred targets for retrovirus integration.

Authors:  C C Shih; J P Stoye; J M Coffin
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

6.  Dsi-1, a region with frequent proviral insertions in Moloney murine leukemia virus-induced rat thymomas.

Authors:  S Vijaya; D L Steffen; C Kozak; H L Robinson
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

7.  Concerted activation of two potential proto-oncogenes in carcinomas induced by mouse mammary tumour virus.

Authors:  G Peters; A E Lee; C Dickson
Journal:  Nature       Date:  1986 Apr 17-23       Impact factor: 49.962

8.  Analysis of neoplasms induced by Cas-Br-M MuLV tumor extracts.

Authors:  K L Holmes; W Y Langdon; T N Fredrickson; R L Coffman; P M Hoffman; J W Hartley; H C Morse
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

9.  Identification of a common helper provirus integration site in Abelson murine leukemia virus-induced lymphoma DNA.

Authors:  Y Poirier; C Kozak; P Jolicoeur
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

10.  Characterization of AKR murine leukemia virus sequences in AKR mouse substrains and structure of integrated recombinant genomes in tumor tissues.

Authors:  W Quint; W Quax; H van der Putten; A Berns
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

View more
  12 in total

Review 1.  Mouse chromosome 9.

Authors:  D M Kingsley
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR.

Authors:  Kathryn E Boyd; Ying-Yi Xiao; Kai Fan; Amanda Poholek; Neal G Copeland; Nancy A Jenkins; Archibald S Perkins
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

3.  Genetic mapping of opioid binding protein gene(s) to mouse chromosome 9.

Authors:  A Chakraborti; D L Lippman; H H Loh; C A Kozak; N M Lee
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

4.  Oncogene activation in myeloid leukemias by Graffi murine leukemia virus proviral integration.

Authors:  C Denicourt; E Edouard; E Rassart
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  Members of the GATA family of transcription factors bind to the U3 region of Cas-Br-E and graffi retroviruses and transactivate their expression.

Authors:  C Barat; E Rassart
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  Differentiation arrest and stromal cell-independent growth of murine erythroleukemia cells are associated with elevated expression of ets-related genes but not with mutation of p53.

Authors:  R J Nibbs; K Itoh; W Ostertag; P R Harrison
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  Drug-mediated inhibition of Fli-1 for the treatment of leukemia.

Authors:  Y-J Li; X Zhao; L M Vecchiarelli-Federico; Y Li; A Datti; Y Cheng; Y Ben-David
Journal:  Blood Cancer J       Date:  2012-01-27       Impact factor: 11.037

8.  The role of translation initiation regulation in haematopoiesis.

Authors:  Godfrey Grech; Marieke von Lindern
Journal:  Comp Funct Genomics       Date:  2012-05-09

9.  Targeted integration of adeno-associated virus (AAV) into human chromosome 19.

Authors:  R J Samulski; X Zhu; X Xiao; J D Brook; D E Housman; N Epstein; L A Hunter
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

Review 10.  Molecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumors.

Authors:  Monica Cantile; Laura Marra; Renato Franco; Paolo Ascierto; Giuseppina Liguori; Annarosaria De Chiara; Gerardo Botti
Journal:  Med Oncol       Date:  2013-01-18       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.